Reduction in Subcutaneous Insulin Requirements in Tetraplegic Type 1 Diabetic with Cervical Spinal Cord Injury Following Pramlintide Treatment
ABSTRACT: Objective: To report a massive increase in subcutaneous insulin requirements following spinal cord injury in a type 1 diabetic and how it was managed over a 22-month period with pramlintide. Methods: A case report and brief literature review is presented. Results: The patient is a 43-year...
Main Authors: | Frank Salamone, BA, Brian A. Berelowitz, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520300183 |
Similar Items
-
Effects of Combined Upper Limb Robotic Therapy in Patients With Tetraplegic Spinal Cord Injury
by: Joo Hwan Jung, et al.
Published: (2019-08-01) -
Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes
by: John Pullman, et al.
Published: (2006-09-01) -
Rubrospinal neurons after chronic cervical spinal cord injury
by: Kwon, Brian K.
Published: (2009) -
Pharmacological neuroprotection in cervical spinal cord injury
by: Lee, Jae Ho
Published: (2010) -
Pharmacological neuroprotection in cervical spinal cord injury
by: Lee, Jae Ho
Published: (2010)